Points-to-consider: the mRNA vaccine reflection paper

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

著者情報

Teruhide YAMAGUCHI
Kanazawa-Institute of Technology, 7-1 Ohgigaoka, Nonoichi, Ishikawa 921-8501, Japan
Nihon Pharmaceutical University, 210281 Komuro, Inamachi Kitaadachi-gun, Saitama 362-006, Japan
Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
Takashi OGAWA
Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
Tsuyoshi ANDO
Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
Satoshi YOSHIDA
Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
Akira SAKURAI
Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
Kazushige MAKI
Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan
Yasuhiro ARAKI
Japan Pharmaceuticals and Medical Devices Agency, Shi-Kasumigaseki Bldg, 3-3-2 kasumigaseki, Chiyoda-ku, Tokyo 100-0013, Japan